TXMD

TherapeuticsMD (TXMD)

TherapeuticsMD Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TXMD

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/11	05 : 18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TXMD	TherapeuticsMD Inc
2024/05/11	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXMD	TherapeuticsMD Inc
2024/05/11	05 : 05	Business Wire	TherapeuticsMD Announces First Quarter 2024 Financial Results	NASDAQ:TXMD	TherapeuticsMD Inc
2024/03/30	05 : 00	Business Wire	TherapeuticsMD Announces Full Year 2023 Financial Results	NASDAQ:TXMD	TherapeuticsMD Inc
2023/12/08	06 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/12/07	01 : 36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/11/17	23 : 28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TXMD	TherapeuticsMD Inc
2023/11/17	23 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/11/15	06 : 05	Business Wire	TherapeuticsMD Announces Third Quarter 2023 Financial Results	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/22	05 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/22	05 : 20	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/19	06 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/14	20 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/14	20 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/14	19 : 50	Business Wire	TherapeuticsMD Announces Second Quarter 2023 Financial Results	NASDAQ:TXMD	TherapeuticsMD Inc
2023/07/20	06 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/07/20	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/07/20	06 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/07/11	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXMD	TherapeuticsMD Inc
2023/07/07	05 : 38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXMD	TherapeuticsMD Inc
2023/06/30	21 : 29	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TXMD	TherapeuticsMD Inc
2023/06/30	06 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/06/30	06 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/06/28	20 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/18	06 : 05	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/18	06 : 02	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/16	05 : 38	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/16	05 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/16	05 : 05	Business Wire	TherapeuticsMD Announces First Quarter 2023 Financial Results	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/06	06 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TXMD	TherapeuticsMD Inc